CBU
PACB icon

CIBC Bancorp USA’s Pacific Biosciences PACB Stock Holding History

CIBC Bancorp USA’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.2K Buy
16,193
+1,679
+12% +$2.44K ﹤0.01% 1913
2026
Q1 		$19.2K Buy
+14,514
New +$26K ﹤0.01% 1740
2025
Q3 		$37.7K Buy
+29,435
New +$39.9K ﹤0.01% 1435

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

CIBC Bancorp USA's PACB Position: Q2 2026 in Review

CIBC Bancorp USA increased its Pacific Biosciences (PACB) stake by 12% in Q2 2026, buying an estimated $2.44K and bringing the position to 16,193 shares worth $27.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1913.

CIBC Bancorp USA first reported a position in PACB in Q3 2025 and has held it in 3 quarters since. The position peaked at $37.7K in Q3 2025. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • CIBC Bancorp USA held 16,193 shares of Pacific Biosciences worth $27.2K as of Q2 2026.
  • CIBC Bancorp USA bought 1,679 Pacific Biosciences shares in Q2 2026, an estimated $2.44K.
  • Pacific Biosciences made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1913 holding.
  • CIBC Bancorp USA first reported a position in Pacific Biosciences in Q3 2025 and has held it in 3 quarters since.
  • CIBC Bancorp USA's Pacific Biosciences position peaked at $37.7K in Q3 2025.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.